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The cornified cell envelope is formed during the
terminal differentiation of epidermis through cross-
linking of specific proteins by transglutaminases. The
specific arrangement of individual protein in the
cornified cell envelope and participation of individual
protein in the cornified cell envelope at different
regions of skin, i.e., palm, foreskin, lips, etc. are not
clearly understood. In order to understand the pattern
and expression schedule of each individual precursor
protein during the differentiation and formation of
cornified cell envelope, the expression of precursor
proteins in developing human fetal skins from the first
to the third trimester were examined by immunohisto-
chemical studies. Involucrin was found in the periderm
and intermediate layer from 14 wk estimated gesta-
tional age, while loricrin and small proline-rich protein
1 were found in the periderm from 16 wk estimated
gestational age. Filaggrin and trichohyalin that are
The cornified cell envelope (CE), an essential epidermalintegument, is thought both to serve a barrier functionfor organisms, and to help maintain the structuralintegrity of the epidermis (Hohl, 1990; Reichert et al,1993). It is formed during the terminal differentiation
process as several precursor proteins are cross-linked by transglutam-
inases (TGase) (Steven and Steinert, 1994; Steinert, 1995). The CE
is composed of a numerous precursor proteins, such as involucrin
(Rice and Green, 1977; Eckert et al, 1993), loricrin (Mehrel et al,
1990; Hohl et al, 1991), keratolinin/cystatin A (Zettergren et al,
1984; Takahashi et al, 1992), small proline rich-protein (SPRR)
(Kartasova et al, 1988, 1996), and SKALP/elafin (Wiedow et al,
1990; Nara et al, 1994). All of these precursor proteins are
good substrates for calcium-dependent TGase, which catalyzes the
formation of ε(γ-glutamyl)lysine isopeptide bond (Goldsmith et al,
1974; Steinert and Idler, 1979). Therefore, it is understandable that
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absent in the adult cornified cell envelope were found
in the granular and horny layers from 24 wk estimated
gestational age. The precursor proteins except
trichohyalin did not change their patterns after the
onset of initial expression during development.
Trichohyalin was transiently expressed in the granular
and horny layers of the epidermis from 24 wk estimated
gestational age with peak expression at 27 wk estimated
gestational age, but was not detected in adult skin. In
hair follicles, trichohyalin expression was stable with-
out change from 20 wk estimated gestational age.
These findings suggest that fetal skin may have different
sets of barriers from the second trimester; the imma-
ture cornified cell envelope is formed in the early
second trimester and the mature cornified cell envelope
is formed in the late second or early third trimester
when filaggrin and trichohyalin appear. Key words:
terminal differentiation/trichohyalin. J Invest Dermatol
112:882–886, 1999
the proper expression of enzymes and their substrates is an essential
regulatory process in forming the CE to serve a barrier function.
Expression of precursor proteins, markers of terminal differenti-
ation, was determined by various factors, including calcium, retinoic
acid, and cultural conditions, such as exposed or submerged cultures
(Yuspa et al, 1982; Lichti et al, 1985; Nagae et al, 1987). The
normal epidermis proceeds in multiple stages to form the mature
CE, but cultured cells are not able to complete all stages, causing
different forms of the CE in vitro (Nagae et al, 1987). Similarly,
prenatal skin is exposed to the aqueous condition of the placenta
instead of air, suggesting that different sets of differentiation are
possible in developing fetal skin. In addition, the periderm is found
as a simple epithelium of fetal skin with an unique structure. It
functions in the outermost layer until the second trimester, in
contrast with the stratifying squamous epithelium in mature skin
(Holbrook, 1979, 1991). To date, however, there are only a few
reports on the sequential changes in the markers of terminal
differentiation during fetal skin development in humans. Involucrin
was expressed in the periderm and intermediate layer, while loricrin
was detected in the intermediate cells of human skin from the first
trimester (Holbrook et al, 1991). SPRR1 expression was observed
from the early second trimester in the periderm (Kartasova et al,
1988). In the late second or early third trimester, filaggrin expression
was detected in the granular layer of the epidermis, whereas
keratohyalin granules appear with the onset of epidermal keratiniz-
ation (Holbrook, 1991). Trichohyalin is a new putative precursor
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of the CE which acts as a matrix protein to bind with keratin
intermediate filaments (Lee et al, 1993). Unfortunately, few studies
have been reported on the relative relationship among the CE
precursors in terms of their sequential orders and localization
during fetal skin development. Also, trichohyalin expression in the
epidermis and hair follicles has not been reported in fetal skin.
Under the assumption that transient barrier structures exist in
fetal skin with different sets of differentiation process, we have
evaluated the expression of the markers of terminal differentiation
from the first to the third trimester, consecutively, in human fetuses.
From this study, fetal skin is noted to be similar to postnatal mature
skin in the sequential expression of precursor proteins of the CE.
Also, trichohyalin was detected in the epidermis transiently as a
component of the CE, whereas it was stably expressed in hair
follicles, suggesting that a different regulatory mechanism is implic-
ated in trichohyalin expression between the epidermis and hair
follicles.
MATERIALS AND METHODS
Fetal skin samples Human fetal samples were obtained by dilation and
curettage (D&C) or by an artificial termination of pregnancy. Consent
forms were approved by the Committee for Human Experimental Study
of Chonnam University Medical School, and all practices were performed
under the rules for human sampling. The estimated gestational age (EGA)
of fetal samples ranged from 10 wk to 32 wk, and the ages were determined
by mothers’ histories of last menstruation. Results on immunohistochemical
experiments were repeated at least three times with different samples of
the same EGA.
Antibodies to filaggrin, loricrin, involucrin, SPRR1, and
trichohyalin A monoclonal antibody to anti-human filaggrin and a
polyclonal antibody to anti-human involucrin were purchased from
Biomedical Technologies (Stoughton, MA). The anti-filaggrin antibody
was extracted from mice with partially purified filaggrin from the newborn
human epidermis (Lynley and Dale, 1983). The anti-involucrin anti-serum
was obtained from rabbits with purified cultured human epidermal cells
(Murphy et al, 1984). A polyclonal anti-human loricrin antibody was raised
against the carboxyl-terminal peptide of human loricrin in rabbits (Hohl
et al, 1991). A polyclonal anti-SPRR1 antibody was raised against the
carboxyl-terminal peptide of human SPRR1 in rabbits (Kartasova et al,
1988). A polyclonal anti-trichohyalin antibody was obtained from rabbits
with recombinant human trichohyalin of 1250–1849 residues (domain 8)
located in the carboxy-terminus (Tarcsa et al, 1996).
Immunohistochemical staining Specimens from the skin of thigh
were fixed in 10% formalin solution for the immunohistochemical labeling
with corresponding antibodies. After the fixation, the specimens were
rinsed in absolute alcohol, rehydrated to 70% ethanol, and were processed
for paraffin embedding. Paraffin sections, 5 µm in thickness, were deparaf-
finized by placing them through two changes of xylene. The sections were
preincubated with 3% hydrogen peroxide in distilled water for 10 min to
block endogenous peroxidase activity. The slides were then washed in
Tris-buffered saline (pH 7.2). The sections were incubated with primary
antibodies as follows: 1:10 titer at room temperature for 30 min with anti-
involucrin; 1:200 titer at room temperature for 2 h with anti-loricrin;
1:200 titer at room temperature for 30 min with anti-filaggrin; 1:100 titer
at room temperature for 2 h with anti-SPRR1; and 1:50 titer at room
temperature for 30 min with anti-trichohyalin antibody. After incubation
with the primary antibodies, the samples were rinsed with Tris-buffered
saline and re-incubated with a biotinylated secondary antibody (anti-rabbit,
mouse immunoglobulins) from LSAB kit (DAKO, CA) for 15 min at
room temperature. After washing, the sections were incubated for 15 min
with the streptavidin conjugated with horseradish peroxidase. They were
incubated for 5 min with 3,39-diaminobenzidine tetrahydrochloride or 3-
amino-9-ethyl carbazole as the chromogenic substrate, and were coun-
terstained with Meyer’s hematoxylin. As a negative control, sections were
incubated with nonimmunized sera instead of primary antibodies.
In immunohistochemical staining for trichohyalin, the sections were
boiled for 5 min at 121°C, 15 lb per in2 in an autoclave prior to incubating
with the anti-trichohyalin antibody to restore its antigenicity.
Characterization of immunoreactivity All sections were examined
under the light microscope. The expression levels of differentiation markers
were graded with a scale ranging from 0 to 31 for their intensity
accordingly.
RESULTS
Involucrin, loricrin, and SPRR1 were expressed from the
early second trimester, while filaggrin was expressed from
the late second trimester
Involucrin was expressed from 14 wk EGA in the periderm and
intermediate layer (Fig 1b), and it was observed in the granular
and upper spinous layers of mature skin (Fig 1d). Loricrin and
SPRR1 were expressed from 16 wk EGA in the periderm (Fig 1f,
j), and they were observed in the granular layer of mature skin
(Fig 1h, l). SPRR1 expression was also observed focally in the
upper spinous layer of mature skin (Fig 1l). Filaggrin expression
was observed from 24 wk EGA in the granular and horny layers
of the entire epidermis (Fig 1o, p), whereas it was observed focally
from 22 wk EGA in the perifollicular epidermis (Fig 1n). These
precursor proteins did not demonstrate changes in their expression
patterns after their initial onset of fetal skin development (Table I).
In experiments to exclude the possibility of nonspecific background
staining, especially in the early stages, samples of 10 and 12 wk
EGA were negatively stained when they were incubated with
preimmune sera instead of primary antibodies (Fig 2).
Trichohyalin is transiently expressed in the epidermis during
late stages of fetal skin development, whereas it is stably
expressed in hair follicles from the mid second trimester
Trichohyalin was transiently expressed in the granular and horny
layers of the epidermis from 24 wk EGA (Fig 3c), with a peak
expression at 27 wk EGA (Fig 3d). Trichohyalin expression
diminished after 32 wk EGA (Fig 3e), and it was not detected in
adult skin (Fig 3f). In contrast, trichohyalin expression was stable
in hair follicles without any changes since it started expression from
20 wk EGA in the inner root sheath and medulla (Fig 3b) (Table I).
DISCUSSION
This study was carried out to establish a better understanding of
the functional aspects of fetal skin by evaluating certain markers of
terminal differentiation, namely the precursor proteins of the CE.
Holbrook (1979) suggested that the periderm has a barrier function
until the underlying epidermis keratinizes with the formation of
the epidermal CE from the late second or early third trimester.
During the first trimester, the amniotic environment supplies
nutrition to the fetus for growth, so the periderm is not a barrier
in this early stage (Holbrook, 1979). The periderm was also reported
to contain many cytoplasmic vesicles to exchange fluid or other
materials over 12–16 wk EGA. Later it undergoes a transformation
into a layer of flattened squames with aggregates of keratin filaments
(Hoyes, 1968; Breathnach, 1971). From this study, precursor
proteins, except filaggrin and trichohyalin, were identified in the
periderm stages of the second trimester, suggesting that the periderm
differentiates into a functional barrier as keratinization proceeds
during this stage. The sequential order of their expression in fetal
skin was similar to that of their incorporation into the CE in
postnatal skin. Involucrin starts expression in the earliest stage
followed by loricrin and SPRR. Filaggrin and trichohyalin are
expressed in the last stage, causing the formation of the mature
CE. An existing model for the hierarchical order of CE assembly
predicts that involucrin and cystatin A act as a scaffold in the early
stage of assembly, then loricrin and SPRR are deposited, and finally
filaggrin is incorporated in the very late stage (Steinert, 1995).
Comparing our results with the previous reports, it appears that
there are discrepancies in the expression of some precursor proteins
in human skin. Our study showed that involucrin was present from
14 wk EGA in the periderm and intermediate layer, whereas it
was reported to be found from 12 wk EGA (Watt et al, 1989) or
from 8 to 9 wk EGA (Holbrook et al, 1991). Loricrin expression
was reported to be positive in intermediate cells (Bickenbach et al,
1995) from 7 to 8 wk EGA (Holbrook et al, 1991). The finding
of loricrin expression only in the intermediate layer is exceptional,
because other markers were found in the periderm. In fact,
expression patterns of marker proteins in terms of their localization
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Figure 1. Involucrin, loricrin, SPRR1, and filaggrin are expressed in the epidermis from the early second to the third trimester.
Immunohistochemical staining of involucrin, loricrin, SPRR1, and filaggrin was performed with human fetal skin samples of 10–32 wk EGA as described
in Materials and Methods. Initial expression of involucrin, loricrin, SPRR1, and filaggrin are observed from samples of 14 wk (b), 16 wk (f), 16 wk (j),
and 24 wk (o) EGA, respectively. Immunoreactivities of involucrin are shown in samples of 12 wk (a), 14 wk (b), 22 wk (c), and 26 wk (d) EGA.
Immunoreactivities of loricrin are shown in samples of 14 wk (e), 16 wk (f), 24 wk (g), and 26 wk (h) EGA. Immunoreactivities of SPRR1 are shown
in samples of 14 wk (i), 16 wk (j), 22 wk (k), and 32 wk (l) EGA. Immunoreactivities of filaggrin are shown in samples of 20 wk (m), 22 wk (n), 24 wk
(o), and 32 wk (p). Scale bar: 50 µm.
Table I. Immunoreactivities of precursor proteins of the cornified cell envelope during fetal skin development in human
Immunoreactivity
Precursor No. of
Periderm (granular)a Intermediate layer (spinous)b Basal layer (basal)c
proteins samples 14 16 20 22 24 32 14 16 20 22 24 32 14 16 20 22 24 32
Involucrin 5 111 111 111 111 111 111 11 11 11 11 11 11 – – – – – –
Loricrin 5 – 11 11 11 11 11 – – – – – – – – – – – –
SPRR1 3 – 11 11 11 11 11 – – – – 1b 1b – – – – – –
Filaggrin 4 – – – –c 11 11 – – – – – – – – – – – –
Trichohyalin 3 – – –d – 11 1 – – – – – – – – – – – –
aThe epidermis consisted of the periderm, intermediate, and basal layers until 22 wk EGA, but they were replaced with the granular, spinous, and basal layers from 24 wk
EGA as the periderm disappeared.
bSPRR1 expression was focally positive in the upper spinous layer of the mature epidermis.
cFilaggrin expression was focally positive from 22 wk EGA in the perifollicular epidermis, while it was positive from 24 wk EGA in the entire epidermis.
dTrichohyalin expression was positive from 24 wk EGA in the epidermis, but it was positive from 20 wk EGA in hair follicles.
did not change markedly after initial onset of expression (Table I).
From this study, loricrin was found in the periderm of developing
skin from 16 wk EGA, and the pattern did not change in mature
skin, to be detected only in the granular layer.
In SPRR1 expression, our result is largely consistent with the
previous reports which show that it is localized in the periderm of
mice (Kartasova et al, 1996) and humans from 15 wk old (Kartasova
et al, 1988). SPRR1 expression was also found in developing hair
follicles (Fig 1k), supporting the previous report that it was present
in the outer layers of follicular infundibulum and isthmus (Koizumi
et al, 1996). The initial expression of filaggrin was observed from
24 wk EGA, whereas the epidermal CE forms as fetal skin reaches
maturation, supporting the previous report (Dale et al, 1985). It is
known that the mature epidermis starts keratinization from this
stage when keratohyalin granules appear, while the periderm sloughs
away (Holbrook, 1991). The finding of focal staining of filaggrin
in the perifollicular epidermis from 22 wk EGA, however, suggests
that the maturation of the follicular epidermis precedes that of the
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interfollicular epidermis with a time-gap in keratinization of fetal
skin. Together, the marker proteins of terminal differentiation did
not change markedly in their expression patterns during fetal skin
development.
The same stage in the initial expression of loricrin and SPRR
implies the presence of a functional relationship between them
during terminal differentiation. From the analysis of peptide
sequences, SPRR is believed to function as cross-bridging protein
between and among the much larger amounts of loricrin (Steinert,
1995). SPRR expression, however, is affected by many factors
since its expression starts in fetal skin. SPRR1 is strongly expressed
in the periderm of a 16 d old fetus in mouse, whereas the expression
was not detectable in a newborn mouse (Kartasova et al, 1996).
The age-associated decrease of SPRR1 was also reported in an
mRNA expression study of human skin (Yaar et al, 1995). Further
studies should be performed on factors to regulate SPRR expression
during terminal differentiation, including age, location of skin, and
various exogenous stimuli in normal and pathologic conditions
(Kartasova et al, 1988; Yaar et al, 1995; Koizumi et al, 1996).
Figure 2. Samples treated with preimmune sera show no
background staining. Fetal skin samples of 10 wk EGA (a) and 12 wk EGA
(b) were stained negatively, when they were incubated with preimmune sera
instead of specific primary antibodies. Scale bar: 50 µm.
Figure 3. Trichohyalin is transiently
expressed in the fetal epidermis, but it
is stably expressed in hair follicles from
20 wk EGA. Immunoreactivities of
trichohyalin are shown in samples of 18 wk
(a), 20 wk (b), 24 wk (c), 27 wk (d),
and 32 wk (e) EGA. Immunoreactivity of
trichohyalin is not detected in the adult
epidermis (f). In hair follicles, trichohyalin
is stably expressed in the inner root sheath
and medulla from 20 wk EGA (b) without
changes during development. Scale bar:
50 µm.
Trichohyalin is present mainly in the inner root sheath and medul-
lary cells of hair follicles, as well as in the nail matrix, tongue, hard
palate, and epidermis of humans (O’Guin and Manabe, 1991;
O’Keefe et al, 1993). In the epidermis, it is transiently expressed only
in neonatal foreskin, and is not detected in adult skin. But, analysis of
the human trichohyalin gene suggests that trichohyalin is a precursor
protein of the epidermal CE, because of its similarity to involucrin;
both consist largely of peptide repeats that possess similar periodicity
in charged residues to form a single-stranded helical rod as a scaffold
proteins (Lee et al, 1993). Trichohyalin is also similar to filaggrin in
gene structure: both are composed of three exons and intervening
introns; both have two EF-hands at the amino terminus, enabling
them to bind with calcium; and both are regarded as an intermediate
filament associated protein to bind with keratin filaments (Lee et al,
1993). From this study, trichohyalin and filaggrin have an intimate
functional relationship as precursor proteins, in that both are
expressed in the granular and horny layers at the same stage of 24 wk
EGA. In fact, filaggrin and trichohyalin are reported to be found as
hybrid granules in the normal foreskin, and pathologic conditions of
psoriasis and molluscum contagiosum (Manabe and O’Guin, 1994;
Manabe et al, 1996; Ishida-Yamamoto et al, 1997). Further studies
should be done to confirm the role of filaggrin as a component of the
CE, because it may be a contaminant of the CE during the preparation
of them as an intermediate filament associated protein (Steinert and
Marekov, 1995). Trichohyalin expression, however, was unstable in
the epidermis to be found only in the late stage of fetal skin develop-
ment, suggesting that trichohyalin is a minor component in forming
the epidermal CE. On the other hand, trichohyalin expression in hair
follicles was stable without changes of expression pattern from 20 wk
EGA, implying that a differentmechanismexists to control trichohya-
lin expression between the epidermis and hair follicles.
In contrast with the stratified epithelium of the mature epidermis,
the periderm is a single cell layer, which may lead to a different
mechanism in forming a barrier structure. For example, cultured
human keratinocytes produce the fragile CE that differs markedly
with the rigid CE of keratinocytes in vivo in amino acid composition
primarily due to the absence of loricrin (Mehrel et al, 1990). Even in
normal skin, therewas intra- and inter-individual variations inpeptide
composition of the CE (Legrain et al, 1991). Therefore, it is suggested
that the periderm uses different sets of precursor proteins in forming
a barrier structure by assembling the available precursors. A similar
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idea has been presented as a ‘dust-bin hypothesis’: the composition
of the CE might be determined by available substrate proteins at the
moment when TGase mediate cross-linking (Michel et al, 1987;
Hohl, 1990; Reichert et al, 1993). In this study, there was a drastic
change in expression patterns of the precursor proteins during fetal
development: (i) they were not identified in the first trimester; (ii)
several precursor proteins are expressed from the early second trimes-
ter; and (iii) filaggrin and trichohyalin are expressed from the late
second or early third trimester as a final stage. These results suggest
that the immature CE is formed in the early second trimester, whereas
the mature CE is formed in the late second or early third trimester in
adult skin. Therefore, the periderm is not a functional barrier in the
first trimester in that no identifiable precursors of the CE are present
at this stage, but it becomes a functional barrier as the epidermis
differentiates in the second trimester, supporting the previous report
(Holbrook, 1991). Our morphologic findings are consistent with
previous biochemical results which show that an osmotic gradient
develops between amniotic fluid and fetal and maternal plasmas from
the second trimester (Breathnach, 1971; Benzie et al, 1974).
In summary, the precursor proteins of the CE initiates their
expression from the early second trimester in a sequential order of
involucrin, loricrin and SPRR1, and filaggrin and trichohyalin,
which is similar to the sequential order of deposits in the CE of
the postnatal mature epidermis. Therefore, fetal skin is a good
model to investigate the dynamic process of terminal differentiation
of skin.
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